Stockreport

Vifor Pharma and Akebia Therapeutics Announce Expansion of License Agreement

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF Expanded license creates opportunity for vadadustat to be provided to up to 60% of U.S. dialysis patients, subject to FDA approval ZURICH & CAMBRID [Read more]